Xencor, Inc.
BISPECIFIC CHECKPOINT INHIBITOR ANTIBODIES
Last updated:
Abstract:
The present invention is directed to bispecific, heterodimeric checkpoint antibodies.
Status:
Application
Type:
Utility
Filling date:
7 Jun 2019
Issue date:
19 Dec 2019